• Home
  • About Us
  • Contact
  • Careers
  • More
    • Home
    • About Us
    • Contact
    • Careers
  • Home
  • About Us
  • Contact
  • Careers

Materializing Superior Patient Outcomes

Materializing Superior Patient OutcomesMaterializing Superior Patient OutcomesMaterializing Superior Patient Outcomes

Materializing Superior Patient Outcomes

Materializing Superior Patient OutcomesMaterializing Superior Patient OutcomesMaterializing Superior Patient Outcomes

Pramand develops implantable medical devices from novel, proprietary hydrogel materials that improve patient outcomes while lowering the cost of therapy. We self-fund our projects through preclinical development and work with financial partners for clinical development and commercialization.

Our Capabilities

Our Capabilities

Our Capabilities

Pramand’s portfolio of proprietary hydrogel technology positions us to be the leader in creating new hydrogel based medical devices to address unmet medical needs in a range of surgical interventions. 

Our Impact

Our Capabilities

Our Capabilities

Our team has launched over ten medical device companies based on hydrogel technology. These companies have generated over $4B in value and exits and have helped over 5 million patients worldwide achieve better outcomes.

Portfolio

Hydrogel implant for minimizing intrauterine adhesions (IUAs)

Dural sealant to provide watertight dural closure following craniotomy

Hemostatic sealant patch for controlling moderate surgical bleeding


www.rejoni.com

Hemostatic sealant patch for controlling moderate surgical bleeding

Dural sealant to provide watertight dural closure following craniotomy

Hemostatic sealant patch for controlling moderate surgical bleeding


www.sealonix.com

Dural sealant to provide watertight dural closure following craniotomy

Dural sealant to provide watertight dural closure following craniotomy

Dural sealant to provide watertight dural closure following craniotomy


www.craniseal.com

Recent News

Copyright © 2024 Pramand LLC

  

These statements have not been evaluated by the Food and Drug Administration.


 PRA-MKT-0006 Rev. B

Cover image by upklyak on Freepik

This website uses cookies.

We use cookies to analyze website traffic and optimize your website experience. By accepting our use of cookies, your data will be aggregated with all other user data.

Accept